Show simple item record

dc.contributor.authorSmuts, Corneliusen_US
dc.contributor.authorHon, G.M.
dc.contributor.authorHassan, M.S.
dc.contributor.authorVan Rensburg, S.J.
dc.contributor.authorAbel, S.
dc.contributor.authorMarais, D.W.
dc.contributor.authorVan Jaarsveld, P.
dc.contributor.authorHenning, F.
dc.contributor.authorErasmus, R.T.
dc.contributor.authorMatsha, T.
dc.identifier.citationSmuts, C. et al. 2009. Erythrocyte membrane fatty acids in patients with multiple sclerosis. Multiple Sclerosis, 15(6):759-62, Jun. []en_US
dc.identifier.issn1477-0970 (Online)
dc.description.abstractBACKGROUND: Reports on fatty acids levels in multiple sclerosis remain inconclusive. OBJECTIVE: To determine the erythrocyte membrane fatty acid levels in multiple sclerosis patients and correlate with Kurtzke Expanded Disability Status Scale. METHODS: Fatty acid composition of 31 multiple sclerosis and 30 control individuals were measured by gas chromatography. RESULTS: The membrane phosphatidylcholine C20:4n - 6 concentration was lower in the multiple sclerosis patients when compared to that of the control group, P = 0.04 and it correlated inversely with the EDSS and FSS. CONCLUSION: Decrease in C20:4n - 6 in the erythrocyte membrane could be an indication of depleted plasma stores, and a reflection of disease severity.
dc.publisherSAGE Publications
dc.titleErythrocyte membrane fatty acids in patients with multiple sclerosisen_US

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record